Veranex Blog

Regulatory

6 min read

Navigating FDA’s Latest Guidance Updates for AI-Enabled Medical Devices: A Marketing Submission Guide

As artificial intelligence transforms healthcare innovation, the FDA continues to evolve its regulatory framework for AI-enabled device software...

Read More

4 min read

Optimizing PLM-OEM Collaborations: Key Strategies for a Smooth IVDR Transition

Under Directive 98/69/EC (IVDD), it was common practice for in vitro diagnostic medical devices to be placed on the European market under contractual...

Read More

4 min read

Achieving Regulatory Clearance for a Novel Device – Provisio Medical

Provisio™ SLT IVUS™ System Creating a novel medical device typically includes innovation around treatment, capabilities, cost reduction, or usability...

Read More

2 min read

Ensuring Compliance with New FDA Guidance on Software Documentation & Cybersecurity

New guidance from the FDA replaces similar, but now obsolete, guidance. Some of the guidance was issued in response to the PATCH Act, which is a 2022...

Read More

1 min read

Document Review: A Nuanced Process in Medical Writing

Veranex is determined to provide complete support to our healthcare partners to reach our shared goal of advancing medical care and improving...

Read More

3 min read

Amending Regulation for MDR / IVDR: Key Takeaways for the Diagnostics Industry

The EU Parliament adopted the regulation amending EU 2017/745 (MDR) and EU 2017/746 (IVDR) aiming to protect patients by ensuring the availability of...

Read More

4 min read

2024 IVDR Sprint: 6 Reasons Why You Should Start a Performance Evaluation Early

In accordance with Article 5(3) of Regulation (EU) 2017/746 (IVDR), a performance evaluation must be drawn up for every IVD placed on the European...

Read More

2 min read

Prioritizing Patient Safety and Fostering Innovation with the MHRAs New Roadmap for Medical Devices

On January 9, the United Kingdom (UK)’s Medicines and Healthcare Products Regulatory Agency (MHRA) released a regulatory framework – Roadmap towards...

Read More

2 min read

Implications of FDA’s Quality Management System Regulation (QMSR) Final Rule

On February 2, 2024, the Food and Drug Administration (FDA) issued a final rule to amend the device current good manufacturing practice (CGMP)...

Read More

2 min read

New Proposal for Extended Transition Periods for IVDs: Can Manufacturers Slow Down Transition Efforts? 

On 23 January 2024, the EU Commission published a new proposal for amending the regulations EU 2017/745 (MDR) and EU 2017/746 (IVDR) aiming to...

Read More